BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21370599)

  • 1. Phase II study of combination chemotherapy with docetaxel and carboplatin for locally advanced or recurrent cervical cancer.
    Takekida S; Fujiwara K; Nagao S; Yamaguchi S; Yoshida N; Kitada F; Kigawa J; Terakawa N; Nishimura R
    Int J Gynecol Cancer; 2010 Dec; 20(9):1563-8. PubMed ID: 21370599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy of docetaxel and carboplatin in advanced or recurrent cervix cancer. A pilot study.
    Nagao S; Fujiwara K; Oda T; Ishikawa H; Koike H; Tanaka H; Kohno I
    Gynecol Oncol; 2005 Mar; 96(3):805-9. PubMed ID: 15721429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix.
    Shimada M; Nagao S; Fujiwara K; Takeshima N; Takizawa K; Shoji T; Sugiyama T; Yamaguchi S; Nishimura R; Kigawa J
    Int J Clin Oncol; 2016 Dec; 21(6):1128-1135. PubMed ID: 27380169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical non-squamous carcinoma: an effective combination chemotherapy of taxane, anthracycline and platinum for advanced or recurrent cases.
    Kimura T; Miyatake T; Ueda Y; Ohta Y; Enomoto T; Kimura T; Kamiura S
    Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):200-4. PubMed ID: 22770633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weekly carboplatin and docetaxel for locally advanced primary and recurrent cervical cancer: a phase I study.
    Rein DT; Kurbacher CM; Breidenbach M; Schöndorf T; Schmidt T; König E; Göhring UJ; Blohmer JU; Mallmann P
    Gynecol Oncol; 2002 Oct; 87(1):98-103. PubMed ID: 12468349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine cervix: a phase II study.
    Shimada M; Sato S; Shoji T; Nagao S; Tokunaga H; Sueoka K; Takehara K; Nakamura K; Yamaguchi S; Kigawa J
    Int J Clin Oncol; 2021 Jul; 26(7):1314-1321. PubMed ID: 33826028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
    Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility Study of Adjuvant Chemotherapy Using Taxane Plus Carboplatin for High-Risk Patients With Uterine Cervical Non-Squamous Cell Carcinoma After Radical Hysterectomy.
    Sato S; Shimada M; Ohta T; Kojimahara T; Tokunaga H; Takano T; Yamaguchi S; Tanabe H; Nishio S; Kigawa J
    Int J Gynecol Cancer; 2016 Mar; 26(3):561-7. PubMed ID: 26825829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of combination chemotherapy with docetaxel and carboplatin for elderly patients with advanced non-small cell lung cancer.
    Kim HJ; Kim TG; Lee HJ; Kim JH; Lim BH; Seo JW; Kang EM; Lee BU; Ahn YM; Roh YH; Nam SH; Kim BS
    Lung Cancer; 2010 May; 68(2):248-52. PubMed ID: 19647333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer.
    Kitagawa R; Katsumata N; Ando M; Shimizu C; Fujiwara Y; Yoshikawa H; Satoh T; Nakanishi T; Ushijima K; Kamura T
    Gynecol Oncol; 2012 May; 125(2):307-11. PubMed ID: 22333993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin and paclitaxel in metastatic or recurrent cervical cancer.
    Pectasides D; Fountzilas G; Papaxoinis G; Pectasides E; Xiros N; Sykiotis C; Koumarianou A; Psyrri A; Panayiotides J; Economopoulos T
    Int J Gynecol Cancer; 2009 May; 19(4):777-81. PubMed ID: 19509587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041).
    Nomura H; Aoki D; Takahashi F; Katsumata N; Watanabe Y; Konishi I; Jobo T; Hatae M; Hiura M; Yaegashi N
    Ann Oncol; 2011 Mar; 22(3):636-642. PubMed ID: 20696677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of docetaxel and carboplatin in recurrent platinum-sensitive ovarian, peritoneal and tubal cancer.
    Strauss HG; Henze A; Teichmann A; Karbe I; Baumgart A; Thomssen C; Koelbl H
    Gynecol Oncol; 2007 Mar; 104(3):612-6. PubMed ID: 17069876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix.
    Verschraegen CF; Kavanagh JJ; Loyer E; Bodurka-Bevers D; Kudelka AP; Hu W; Vincent M; Nelson T; Levenback C;
    Cancer; 2001 Nov; 92(9):2327-33. PubMed ID: 11745287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of carboplatin combined with biweekly docetaxel for advanced non-small cell lung cancer.
    Ishimoto O; Sugawara S; Inoue A; Ishida T; Munakata M; Koinumaru S; Hasegawa Y; Suzuki T; Miki H; Saijo Y; Nukiwa T
    J Thorac Oncol; 2006 Nov; 1(9):979-83. PubMed ID: 17409982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Schwartz DL; Montgomery RB; Yueh B; Donahue M; Anzai Y; Canby R; Buelna R; Anderson L; Boyd C; Hutson J; Keegan K
    Cancer; 2005 Jun; 103(12):2534-43. PubMed ID: 15856475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.
    Vasey PA; Jayson GC; Gordon A; Gabra H; Coleman R; Atkinson R; Parkin D; Paul J; Hay A; Kaye SB;
    J Natl Cancer Inst; 2004 Nov; 96(22):1682-91. PubMed ID: 15547181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer.
    Suzuki K; Nagao S; Shibutani T; Yamamoto K; Jimi T; Yano H; Kitai M; Shiozaki T; Matsuoka K; Yamaguchi S
    Gynecol Oncol; 2019 Sep; 154(3):554-557. PubMed ID: 31285082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix.
    Morris M; Gershenson DM; Burke TW; Mitchell MF; Levenback C; Atkinson N; Wharton JT
    Gynecol Oncol; 1994 May; 53(2):234-8. PubMed ID: 8188085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.